Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3659160018 | Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3659161019 | Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet | Has active ingredient | Pseudoephedrine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet | Has manufactured dose form | Prolonged-release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet | Has active ingredient | Brompheniramine maleate | false | Inferred relationship | Existential restriction modifier | ||
| Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet | Is a | Product containing brompheniramine and pseudoephedrine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR